Teladoc Health Inc (TDOC)
11.83
-0.47
(-3.82%)
USD |
NYSE |
May 21, 16:00
11.83
0.00 (0.00%)
After-Hours: 20:00
Teladoc Health Cash from Financing (Quarterly): 1.751M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.751M |
| December 31, 2023 | -1.775M |
| September 30, 2023 | 5.068M |
| June 30, 2023 | 4.208M |
| March 31, 2023 | 3.353M |
| December 31, 2022 | 4.381M |
| September 30, 2022 | 0.634M |
| June 30, 2022 | -1.334M |
| March 31, 2022 | 2.816M |
| December 31, 2021 | 6.625M |
| September 30, 2021 | 0.784M |
| June 30, 2021 | 11.36M |
| March 31, 2021 | 22.18M |
| December 31, 2020 | 70.44M |
| September 30, 2020 | 0.422M |
| June 30, 2020 | 773.22M |
| March 31, 2020 | 15.05M |
| December 31, 2019 | 10.04M |
| September 30, 2019 | 9.153M |
| June 30, 2019 | 5.198M |
| March 31, 2019 | 10.70M |
| Date | Value |
|---|---|
| December 31, 2018 | 7.449M |
| September 30, 2018 | 341.35M |
| June 30, 2018 | 284.62M |
| March 31, 2018 | 12.20M |
| December 31, 2017 | -41.46M |
| September 30, 2017 | 125.40M |
| June 30, 2017 | 268.06M |
| March 31, 2017 | 123.43M |
| December 31, 2016 | -0.195M |
| September 30, 2016 | 15.35M |
| June 30, 2016 | 5.288M |
| March 31, 2016 | 0.236M |
| December 31, 2015 | -0.46M |
| September 30, 2015 | 160.03M |
| June 30, 2015 | 4.414M |
| March 31, 2015 | 0.028M |
| December 31, 2014 | -0.267M |
| September 30, 2014 | 53.13M |
| June 30, 2014 | 16.91M |
| March 31, 2014 | 0.385M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.775M
Minimum
Dec 2023
773.22M
Maximum
Jun 2020
47.18M
Average
4.724M
Median
Cash from Financing (Quarterly) Benchmarks
| Omnicell Inc | 11.93M |
| Phreesia Inc | -4.61M |
| 10x Genomics Inc | 1.638M |
| Biote Corp | -5.409M |
| American Shared Hospital Services | 2.282M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 8.92M |
| Cash from Investing (Quarterly) | -35.51M |
| Free Cash Flow | 199.55M |
| Free Cash Flow Per Share (Quarterly) | -0.1585 |
| Free Cash Flow to Equity (Quarterly) | -27.45M |
| Free Cash Flow to Firm (Quarterly) | -26.59M |
| Free Cash Flow Yield | 10.18% |